Island Pharmaceuticals (ASX:ILA) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Island Pharmaceuticals's Free Cash Flow for the six months ended in Dec. 2023 was A$-1.35 Mil. Island Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Island Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Island Pharmaceuticals's current FCF Yield % is -35.24%.

The historical rank and industry rank for Island Pharmaceuticals's FCF Margin % or its related term are showing as below:

ASX:ILA' s FCF Margin % Range Over the Past 10 Years
Min: -24781.82 Med: -24545.45 Max: -24545.45
Current: -24781.82

During the past 3 years, the highest FCF Margin % of Island Pharmaceuticals was -24545.45%. The lowest was -24781.82%. And the median was -24545.45%.

ASX:ILA's FCF Margin % is ranked worse than
94.93% of 1046 companies
in the Biotechnology industry
Industry Median: -144.01 vs ASX:ILA: -24781.82

Island Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Island Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals FCF Margin % Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

FCF Margin %

-24,545.45

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Island Pharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Island Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's FCF Margin % falls into.

Island Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Island Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-2.7	/	0.011
	=	-24,545.45 %

Island Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.351	/	0
	=	%

Island Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals (ASX:ILA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its lead asset ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases.

Island Pharmaceuticals (ASX:ILA) Headlines

No Headlines